MORGAN STANLEY - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 32 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$04800.0%0.00%
Q2 2019$0480
+26.3%
0.00%
Q1 2019$03800.0%0.00%
Q4 2018$03800.0%0.00%
Q3 2018$0
-100.0%
380
-98.7%
0.00%
Q2 2018$13,000
-38.1%
29,880
-24.2%
0.00%
Q1 2018$21,000
-72.7%
39,400
-66.3%
0.00%
Q4 2017$77,000
+8.5%
116,896
-3.8%
0.00%
Q3 2017$71,000
-40.3%
121,525
-14.3%
0.00%
Q2 2017$119,000
+10.2%
141,848
+77.8%
0.00%
Q1 2017$108,00079,794
+3527.0%
0.00%
Q4 2016$0
-100.0%
2,200
+100.0%
0.00%
Q3 2016$1,0000.0%1,1000.0%0.00%
Q2 2016$1,0000.0%1,1000.0%0.00%
Q1 2016$1,000
-99.2%
1,100
-99.1%
0.00%
Q4 2015$118,000
-40.7%
115,943
-31.3%
0.00%
Q3 2015$199,000
-49.1%
168,750
-15.8%
0.00%
Q2 2015$391,000
+40.6%
200,508
+27.9%
0.00%
Q1 2015$278,000
-6.7%
156,744
-3.3%
0.00%
Q4 2014$298,000
-10.8%
162,044
+17.6%
0.00%
Q3 2014$334,000
+55.3%
137,820
+134.1%
0.00%
Q2 2014$215,000
-13.7%
58,870
+8.0%
0.00%
Q1 2014$249,000
+2390.0%
54,519
+1941.1%
0.00%
Q4 2013$10,000
-95.7%
2,671
-94.4%
0.00%
Q2 2013$233,00047,5340.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders